FDA approves exenatide for use with insulin glargine
Links shared publicly online about this topic.
- 0total visits
FDA approves exenatide for use with insulin glargine
View full resource at endocrinetoday.com
Tags: Diabetes Type 2 Medication, Diabetes Medication, Insulin, FDA, Byetta, Glucophage
Most Recently Shared on October 20, 2011 at 9:08 pm By:
#FDA approves exenatide for use with #insulin glargine http://t.co/RenCcpSr
Byetta Approved as Lantus Add-On :: Diabetes Self-Management
diabetesselfmanagement.com — “On October 19, the US Food and Drug Administration (FDA) approved the Type 2 diabetes medicine Byetta (exenatide) as an add-on treatment to Lantus (insulin glargine) in people who have not achieved blood glucose control with Lantus, diet, and exercise alone...” View full resource at diabetesselfmanagement.com
Most Recently Shared on November 4, 2011 at 3:28 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Byetta has been approved by the FDA as an add-on to Lantus: http://t.co/bu1TmT5z
Medical News: FDA Okays Byetta Plus Insulin Glargine - in Public Health & Policy, FDA General from MedPage Today
medpagetoday.com — “WASHINGTON -- The FDA has approved a new indication for the type 2 diabetes drug exenatide (Byetta) as an add-on therapy with insulin glargine, diet, and exercise for adult patients.” View full resource at medpagetoday.com
Most Recently Shared on October 20, 2011 at 6:35 pm By:
FDA okays Byetta plus insulin glargine: http://t.co/SjJfiocG
New Indication for Exenatide : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on October 20, 2011 at 2:18 pm By:
Bob Finn - Medical News Net Health News
FDA: Exenatide (Byetta) approved for adults with type 2 diabetes as an add-on therapy to insulin glargine. http://t.co/DKg62KJu
Advertisement
